One of the missions at CIB-CSIC consists in making available to society the knowledge and the research results generated in our research center. Thus, we aim to convert our findings in basic research into tangible applications, either through the generation and licensing of intellectual property, and/or through the generation of spin-off companies. Recently, CIB scientists have generated several spin-off companies, such as Secugen, Proretina, and Ankar Pharma.


Secugen    Proretina   AnkarPharma